Cargando…
Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
Accumulation of α-synuclein (α-syn) fibrils in Lewy bodies and Lewy neurites is the pathological hallmark of Parkinson disease (PD). Ligands that bind α-syn fibrils could be utilized as imaging agents to improve the diagnosis of PD and to monitor disease progression. However, ligands for α-syn fibri...
Autores principales: | Bagchi, Devika P., Yu, Lihai, Perlmutter, Joel S., Xu, Jinbin, Mach, Robert H., Tu, Zhude, Kotzbauer, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566091/ https://www.ncbi.nlm.nih.gov/pubmed/23405108 http://dx.doi.org/10.1371/journal.pone.0055031 |
Ejemplares similares
-
Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
por: Zhang, Xiang, et al.
Publicado: (2014) -
Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils
in Vitro
por: Hsieh, Chia-Ju, et al.
Publicado: (2018) -
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015) -
Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020)
por: Li, Xuefei, et al.
Publicado: (2021) -
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics
por: Yamasaki, Tritia R., et al.
Publicado: (2019)